Login
Registrieren
Passwort zurücksetzen
Veröffentlichen & Verteilen
Verlagslösungen
Vertriebslösungen
Themen
Allgemein
Altertumswissenschaften
Architektur und Design
Bibliotheks- und Informationswissenschaft, Buchwissenschaft
Biologie
Chemie
Geowissenschaften
Geschichte
Industrielle Chemie
Informatik
Jüdische Studien
Kulturwissenschaften
Kunst
Linguistik und Semiotik
Literaturwissenschaft
Materialwissenschaft
Mathematik
Medizin
Musik
Pharmazie
Philosophie
Physik
Rechtswissenschaften
Sozialwissenschaften
Sport und Freizeit
Technik
Theologie und Religion
Wirtschaftswissenschaften
Veröffentlichungen
Zeitschriften
Bücher
Konferenzberichte
Verlage
Blog
Kontakt
Suche
EUR
USD
GBP
Deutsch
English
Deutsch
Polski
Español
Français
Italiano
Warenkorb
Home
Zeitschriften
Asian Biomedicine
Band 16 (2022): Heft 3 (June 2022)
Uneingeschränkter Zugang
Uterine tumor resembling ovarian sex-cord tumor: case report and review of the literature
Rong Xu
Rong Xu
,
Liping Shao
Liping Shao
,
Wenling Zhang
Wenling Zhang
und
Zhi-Long Yang
Zhi-Long Yang
| 30. Juni 2022
Asian Biomedicine
Band 16 (2022): Heft 3 (June 2022)
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zusammenfassung
Artikel
Figuren und Tabellen
Referenzen
Autoren
Artikel in dieser Ausgabe
Vorschau
PDF
Zitieren
Teilen
Article Category:
Clinical report
Online veröffentlicht:
30. Juni 2022
Seitenbereich:
145 - 150
DOI:
https://doi.org/10.2478/abm-2022-0018
Schlüsselwörter
case reports
,
fertility preservation
,
immunohistochemistry
,
surgery
,
uterine neoplasms
© 2022 Rong Xu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1
Pelvic computed tomography image showing an unclear defined 11 cm pelvic mass without further abnormalities.
Figure 2
Magnetic resonance imaging and macroscopic findings. (A) T2-weighted image and (B) diffusion-weighted image depicting a high signal intensity in the uterine fibroid.
Figure 3
Dense long spindle cell configurations and hyaline stromal changes under hematoxylin and eosin staining. (A) 40× (scale bar 250 μm), (B) 100× (scale bar 100 μm), (C) 400× (scale bar 50 μm), and (D) 400× (scale bar 50 μm).
Figure 4
Immunohistochemistry of the UTROSCT. The tumor was positive for (A) CD10 (2+), (B) CD99 (3+), (C) CD34 (+), (D) desmin (3+), (E) ER (3+), (F) PR (3+), (G) SMA (3+), and (H) Ki67 (15%+); magnification: 100× (scale bar 100 μm). The antibodies used were as follows: anti-calretinin (catalog No. CCR-0221, Sainuote Biological Technology Co., China; 1:50); anti-CD10 (catalog No. C6D1; Sainuote Biological Technology; 1:50), anti-CD117 (catalog No. EP10, Sainuote Biological Technology; 1:50), anti-CD99 (clone: 013; catalog No. GT212302, Sainuote Biological Technology; 1:50), anti-CD34 (clone: QBend/10; Sainuote Biological Technology; 1:50), anti-D2-40 (catalog No. D2-40, Sainuote Biological Technology; 1:50), anti-desmin (catalog No. C3B7, Sainuote Biological Technology; 1:50), anti-ER (catalog No. FNab02822, Wuhan Feieng Biological Technology Co., China; 1:50), anti-PR (catalog No. YZK7169, Shanghai Yanzhun Biological Technology Co., China; 1:50), anti-SMA (catalog No. C1C1; Sainuote Biological Technology; 1:50), and anti-Ki67 (catalog No. C3G4, Sainuote Biological Technology; 1:50). ER, estrogen receptor; PR, progesterone receptor; SMA, α smooth muscle actin (actin α-2 (ACTA2)); UTROSCT, uterine tumor resembling ovarian sex-cord tumor.